Overview

School Based Malaria Control in Ugandan Schoolchildren

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that schoolchildren treated with IPT using DP over one year of follow-up will have a different risk of clinical malaria compared to those treated with placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Makerere University
Collaborator:
Bill and Melinda Gates Foundation
Treatments:
Artenimol
Dihydroartemisinin
Piperaquine